• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

美国医疗补助计划覆盖人群中成年人肺炎球菌疫苗接种率与潜在医疗条件新诊断率。

Pneumococcal vaccination coverage among US adults enrolled in Medicaid and newly diagnosed with underlying medical conditions.

机构信息

Merck & Co, Inc, Rahway, NJ, USA.

出版信息

Expert Rev Vaccines. 2023 Jan-Dec;22(1):596-607. doi: 10.1080/14760584.2023.2226718.

DOI:10.1080/14760584.2023.2226718
PMID:37401893
Abstract

BACKGROUND

Adults with chronic or immunocompromising conditions have an elevated risk of invasive pneumococcal disease, yet their pneumococcal vaccination rates remain low.

METHODS

This retrospective cohort study used the IBM MarketScan® Multi-State Medicaid database to examine pneumococcal vaccination uptake among adults 19-64 years of age with underlying conditions. Gompertz accelerated failure time model was used to examine factors associated with vaccination.

RESULTS

In the study population of 108,159 adults, the vaccination rate was 4.1% after 1 year of follow-up and 19.4% after 10 years. The mean time from initial diagnosis to vaccination was 3.9 years. Adults aged 35-49 and 50-64 years (relative to 19-34) or those receiving an influenza vaccination were more likely to receive a pneumococcal vaccination. Adults with HIV/AIDS were more likely, while adults with chronic heart or lung disease, alcohol or tobacco dependence, or cancer were less likely to be vaccinated than adults with diabetes mellitus. Adults diagnosed by specialists were less likely to be vaccinated than those diagnosed by primary care providers.

CONCLUSIONS

The rates of pneumococcal vaccination among adults with Medicaid plans and underlying conditions were well under Healthy People Initiative targets. Insights into factors associated with vaccination can inform efforts to improve vaccination rates among this population.

摘要

背景

患有慢性或免疫功能低下疾病的成年人患侵袭性肺炎球菌病的风险较高,但他们的肺炎球菌疫苗接种率仍然很低。

方法

本回顾性队列研究使用 IBM MarketScan®多州医疗补助数据库,调查了患有潜在疾病的 19-64 岁成年人的肺炎球菌疫苗接种情况。采用戈珀特加速失效时间模型来研究与接种相关的因素。

结果

在这项研究的 108159 名成年人中,接种率在随访 1 年后为 4.1%,10 年后为 19.4%。从初次诊断到接种疫苗的平均时间为 3.9 年。与 19-34 岁的成年人相比,35-49 岁和 50-64 岁的成年人(相对于 19-34 岁的成年人)或接受流感疫苗接种的成年人更有可能接种肺炎球菌疫苗。患有艾滋病毒/艾滋病的成年人更有可能接种,而患有慢性心脏或肺部疾病、酒精或烟草依赖或癌症的成年人比患有糖尿病的成年人更不可能接种疫苗。由专科医生诊断的成年人比由初级保健提供者诊断的成年人更不可能接种疫苗。

结论

有医疗补助计划和潜在疾病的成年人的肺炎球菌疫苗接种率远低于《健康人民倡议》的目标。了解与接种相关的因素可以为提高这一人群的接种率提供信息。

相似文献

1
Pneumococcal vaccination coverage among US adults enrolled in Medicaid and newly diagnosed with underlying medical conditions.美国医疗补助计划覆盖人群中成年人肺炎球菌疫苗接种率与潜在医疗条件新诊断率。
Expert Rev Vaccines. 2023 Jan-Dec;22(1):596-607. doi: 10.1080/14760584.2023.2226718.
2
Pneumococcal vaccination coverage among adults newly diagnosed with underlying medical conditions and regional variation in the U.S.美国新诊断出基础疾病的成年人中肺炎球菌疫苗接种率及其地域差异
Vaccine. 2022 Aug 5;40(33):4856-4863. doi: 10.1016/j.vaccine.2022.06.068. Epub 2022 Jul 6.
3
Pneumococcal Vaccine Coverage in Adults Aged 19-64 Years, Newly Diagnosed With Chronic Conditions in the U.S.19-64 岁成年人中慢性疾病新诊断患者的肺炎球菌疫苗覆盖率:美国
Am J Prev Med. 2018 May;54(5):630-636. doi: 10.1016/j.amepre.2018.01.033. Epub 2018 Mar 15.
4
Pneumococcal vaccination coverage among adults aged 19 to 64 years with immuno-compromising conditions, cerebrospinal fluid (CSF) leaks, or cochlear implants in the US.美国免疫功能低下的 19 至 64 岁成人、有脑脊液(CSF)漏或人工耳蜗植入物者的肺炎球菌疫苗接种覆盖率。
Expert Rev Vaccines. 2021 Mar;20(3):331-345. doi: 10.1080/14760584.2021.1898377. Epub 2021 Apr 8.
5
Regional factors associated with pneumococcal vaccination coverage among U.S. adults with underlying chronic or immunocompromising conditions.与美国患有潜在慢性或免疫功能低下疾病的成年人中肺炎球菌疫苗接种覆盖率相关的区域因素。
Hum Vaccin Immunother. 2023 Dec 31;19(1):2194779. doi: 10.1080/21645515.2023.2194779.
6
Pneumococcal vaccine coverage among individuals aged 18 to 64 years old with underlying medical conditions in the UK: a retrospective database analysis.英国18至64岁有基础疾病个体的肺炎球菌疫苗接种率:一项回顾性数据库分析
BMC Public Health. 2020 Oct 21;20(1):1584. doi: 10.1186/s12889-020-09613-5.
7
Pneumococcal vaccination coverage in individuals (16-59 years) with a newly diagnosed risk condition in Germany.德国新诊断出有风险状况的个体(16-59 岁)中肺炎球菌疫苗接种率。
BMC Infect Dis. 2022 Sep 28;22(1):753. doi: 10.1186/s12879-022-07736-1.
8
Clinical and economic burden of pneumococcal disease in US adults aged 19-64 years with chronic or immunocompromising diseases: an observational database study.美国 19-64 岁患有慢性或免疫功能低下疾病的成年人中肺炎球菌疾病的临床和经济负担:一项观察性数据库研究。
BMC Infect Dis. 2018 Aug 29;18(1):436. doi: 10.1186/s12879-018-3326-z.
9
Streptococcus pneumoniae-related illnesses in young children: secular trends and regional variation.幼儿中与肺炎链球菌相关的疾病:长期趋势和地区差异。
Pediatr Infect Dis J. 2003 May;22(5):413-8. doi: 10.1097/01.inf.0000066242.21072.9d.
10
Pneumococcal vaccination coverage in France by general practitioners in adults with a high risk of pneumococcal disease.法国全科医生对肺炎球菌疾病高危成年人的肺炎球菌疫苗接种覆盖率。
Hum Vaccin Immunother. 2021 Jan 2;17(1):162-169. doi: 10.1080/21645515.2020.1756669. Epub 2020 May 19.